Camille Chenevier‐Gobeaux

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · Science · 2020 · 3.1K citations · Full text

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients

Jérôme Hadjadj, Nader Yatim, Laura Barnabei et al. · 2020 · 253 citations · Full text

Immunodeficiencies, Immunology, Severe Covid-19 Patients +19

High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells

Laury Poulain, Pierre Sujobert, Florence Zylbersztejn et al. · Leukemia · 2017 · 140 citations

Hematological Malignancy, Molecular Pharmacology, G6pd Inhibition +9

Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: Comparison with brain natriuretic peptide (BNP)

Camille Chenevier‐Gobeaux, Yann-Érick Claessens, Simon Voyer et al. · Clinica Chimica Acta · 2005 · 94 citations

Urology, Renal Function, Sodium Homeostasis +8

Can early cardiac troponin I measurement help to predict recent coronary occlusion in out-of-hospital cardiac arrest survivors?

Florence Dumas, Stéphane Manzo‐Silberman, Jérôme Fichet et al. · Critical Care Medicine · 2012 · 85 citations